ChemoSafe 1.2.5

The ChemoSafe platform offers a systematic approach to assess the handling of hazardous drugs within healthcare facilities, facilitating a comprehensive evaluation of current practices at every point of interaction. It allows institutions to benchmark their procedures against established international safety and quality standards. By providing targeted recommendations, it supports the development of actionable plans aimed at reducing exposure risks for healthcare workers and patients.

Key features include:

• A straightforward self-assessment process based on yes/no questions, simplifying the evaluation process
• Evidence-based recommendations aligned with international safety and quality standards
• Supporting references for each recommendation to ensure credibility and facilitate review
• Additional resources to assist in implementing suggested improvements
• Offline functionality to accommodate environments with limited internet connectivity
• A tracking feature to monitor progress over time, encouraging continuous enhancement of chemotherapy safety protocols

Developed by IBM through a philanthropic collaboration with the American Cancer Society, ChemoSafe aims to elevate the standards of cancer treatment in low-resource settings, fostering safer handling practices for hazardous drugs across diverse healthcare environments.